Breast Cancer
Expression Pathology Obtains Maryland Funding to Develop Breast Cancer Test
Published in Women's Health Weekly, February 21st, 2008
Expression Pathology Inc. (EPI), a leader in tissue protein analysis, has obtained $125,000 from the State of Maryland to develop a quantitative test for HER2 protein, an important biomarker in breast cancer tissue samples. The funding is part of the Maryland Technology Development Corporation's Maryland Technology Transfer Fund (TEDCO MTTF) and the Maryland Venture Fund's Challenge Investment Program.
Using proprietary tissue processing technologies, EPI is developing a quantitative assay for HER2 (human epidermal growth factor receptor 2) in breast cancer. EPI's Liquid Tissue(R) reagents and Director(TM) laser microdissection slides are used to extract proteins from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Addiction Medicine
Acculturation in the Texas-Mexico border region: Effects on drinking differ by gender - Breast Cancer
Unsuspected protein determines resistance to breast cancer treatment - Breast Cancer
Vet medicine researcher examines link between cancer, Down syndrome - Female Infertility
Significantly higher success rates with artificial insemination - Fetal Alcohol Syndrome
Eye blinks may help to identify children prenatally exposed to alcohol - Smoking
Elderly more likely to deny smoking when asked, says Case Western Reserve University researcher - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
